The 8th JSH International Symposium 2017 in Miyazaki

Date:
Friday, 19 May, - Saturday, 20 May, 2017
Venue:
Seagaia Convention Center in Miyazaki
Theme:
Cell and Gene Therapy for Hematological Disorders -Current Status, Challenges, and Future Perspectives-

Preface

Dear Colleagues

On behalf of the organizing committee, I would like to express our great honor and pleasure of inviting you to the 8th Japanese Society of Hematology (JSH) International Symposium to be held in Miyazaki, Japan, on May 19 and 20, 2017. In this Symposium, recent advances in the cell and gene treatment of various hematological disorders will be discussed under the theme “Cell and Gene Therapy for Hematological Disorders-Current Status, Challenges, and Future Perspectives-”. Attracting clinicians, laboratory scientists, and postdoctoral fellows, the symposium will feature plenary presentations from leaders in cellular and gene therapy, a poster session, and numerous networking opportunities. This International Symposium also includes joint sessions between the JSH, the American Society of Hematology (ASH) and the European Hematology Association (EHA).

In Japan, two laws known as the "The Act on the Safety of Regenerative Medicine" and the "Pharmaceuticals, Medical Devices and the Other Therapeutic Product Act" came into effect on November 25, 2014. New regulations and approval processes were introduced to prompt the delivery of new and effective regenerative medicine to patients suffered from various intractable diseases including hemato-immunological disorders using pluripotent stem cells, tissue specific progenitor cells or committed functional cells. This symposium focuses attention on progress in new hematopoietic stem cell gene therapy for severe congenital disorders, gene-modified and unmodified immune cell therapies and hematopoietic stem cell therapies for hematological malignancies, and emerging technologies including genome editions. Numerous innovative approaches are actively being pursued to both minimize toxicities and enhance the effectiveness of cell and gene therapies. We hope that the participants will enthusiastically discuss the newly raised research topics and clinical questions with world leading experts.

Miyazaki Prefecture is located in the southeastern part of the Kyushu island and famous for its mild climate and home of Myths and Legends. The mythology associated with the creation of Japan and the origin of the imperial line is also compelling, with most stories taking place in Miyazaki. Please explore and enjoy the history, nature and gourmet food in Miyazaki.

I hope you will have an excellent opportunity to acquire advanced knowledge and information on cell and gene therapies for various hematological disorders and to strengthen mutual friendships during the symposium. We will be looking forward to welcoming you to Miyazaki in May 2017.

Kenzaburo Tani
President 8th JSH International Symposium
The Institute of Medical Science, The University of Tokyo